Interesting that a large pharmaceutical company is getting into this. I wonder if it is possible if they could also become a source for other cell types which could be used in clinical trials.

EMD Millipore Introduces Novel Commercially Available Solution for Generating Human Oligodendrocytes

Oligodendrocyte damage is associated with spinal cord injury, multiple sclerosis, and other demyelinating diseases
Having an adequate and reliable supply of human oligodendrocytes has been an ongoing problem for many researchers
New kit allows for efficient generation of human oligodendrocytes from progenitor cells
http://www.millipore.com/press/pr3/p...e_11122010_emd